A.forall’s U.S. subsidiary Milla Pharmaceuticals Inc. announced the launch of the group’s generic version of Precedex, Dexmedetomidine Hydrochloride Injection 200 mcg per 50 mL...
Analog Devices, Inc., a global semiconductor leader, and Flagship Pioneering, the bioplatform innovation company, announced a strategic alliance to accelerate the development of a...
Micropep Technologies (Micropep), the global leader in micropeptide technology, announced a $29 million Series B funding round along with its proprietary discovery platform, Krisalix....
Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and disease-related immune dysfunction, announced its partnership with Springbok Analytics, a life sciences...
Confo Therapeutics, a clinical-stage company and leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), announced the closing of a EUR 60M...
